Anti-TNF has been successfully used for both psoriasis and IBD management, as TNF has an important role in the pathogenesis of both diseases - infliximab, adalimumab, and certolizumab may all induce remission of both diseases [31]. The gene discussed is TNF; the disease is psoriasis.